Kidney transplant (KT) recipients have an up to four times higher cancer incidence, recurrence, and mortality compared to the overall population matched by age and sex.1, 2 In fact, in their study including 21,844 patients receiving a first kidney transplant, Krishnan et al. observed 13.14% of recipients developing de-novo cancer.1
Management of de-novo graft masses in kidney transplantation recipients: focusing on available data and unmet clinical needs / López-Abad, A., Pecoraro, A., Prudhomme, T., Piana, A., Amparore, D., Bertolo, R., Marchioni, M., Muselaers, S., Wu, Z., Territo, A., Campi, R.. - In: MINERVA UROLOGY AND NEPHROLOGY. - ISSN 2724-6051. - ELETTRONICO. - 75:(2023), pp. 242-245. [10.23736/S2724-6051.23.05311-9]
Management of de-novo graft masses in kidney transplantation recipients: focusing on available data and unmet clinical needs
Pecoraro, Alessio;Campi, Riccardo
2023
Abstract
Kidney transplant (KT) recipients have an up to four times higher cancer incidence, recurrence, and mortality compared to the overall population matched by age and sex.1, 2 In fact, in their study including 21,844 patients receiving a first kidney transplant, Krishnan et al. observed 13.14% of recipients developing de-novo cancer.1
| File | Dimensione | Formato | |
|---|---|---|---|
|
R19Y2023N02A0242.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
500.26 kB
Formato
Adobe PDF
|
500.26 kB | Adobe PDF | Richiedi una copia all'autore |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
